HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

14-thioglycolamido-7,8-dihydromorphinone (TAMO)

Also Known As:

TAMO; 14-beta-(thioglycolamido)-7,8-dihydromorphinone

Networked: 20 relevant articles (3 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Arranz, R: 5 articles (04/2005 - 02/2001)
2.	Caballero, M D: 5 articles (04/2005 - 02/2001)
3.	Conde, E: 5 articles (04/2005 - 02/2001)
4.	Lahuerta, J J: 5 articles (04/2005 - 02/2001)
5.	Carreras, E: 4 articles (04/2005 - 01/2003)
6.	García-Laraña, J: 4 articles (04/2005 - 02/2001)
7.	Marín, J: 4 articles (04/2005 - 02/2001)
8.	Sierra, J: 4 articles (04/2005 - 02/2001)
9.	Sureda, A: 4 articles (04/2005 - 01/2003)
10.	Gandarillas, M: 4 articles (10/2004 - 02/2001)

Related Diseases

1.	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/01/2001 - "We investigated the impact of the most commonly used preparative regimens on the outcome of 395 patients with diffuse large cell lymphoma (DLCL), consecutively reported to the registry of the Spanish GEL/TAMO. " 01/01/2003 - "The purpose of this study was to analyse the results and prognostic factors influencing overall survival (OS) and disease-free survival (DFS) in 452 patients diagnosed with diffuse large cell lymphomas (DLCL) treated with high-dose therapy (HDT) included in the Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL-TAMO) Spanish registry. " 01/01/2003 - "High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group." 10/01/2004 - "Here we evaluate the results of high-dose chemotherapy and autologous stem-cell transplantation (HDC/ASCT) in 114 patients included in the GEL/TAMO registry between January 1990 and December 1999 with diffuse large B-cell lymphoma who failed to achieve complete remission (CR) with front-line conventional chemotherapy. "
2.	Hodgkin Disease (Hodgkin's Disease) 08/01/1997 - "Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative group." 04/01/2005 - "To analyse outcome and prognostic factors for overall survival (OS) and time to treatment failure (TTF) in 357 patients with Hodgkin's lymphoma (HL) undergoing an autologous stem cell transplantation (ASCT) after a first relapse and reported to the The Grupo Espanol de Linfomas/Trasplante Autologo de Medula Osea (GEL/TAMO) Cooperative Group. "
3.	Peritoneal Fibrosis 12/21/2018 - "Tamoxifen (Tamo) has been clinically proven effective in a series of fibrotic diseases, such as PD-associated encapsulating peritoneal sclerosis (EPS), but the mechanisms underlying Tamoxifen's protective effects are yet to be defined. "
4.	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 07/01/2007 - "Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from The Gel-Tamo Study Group." 12/01/2003 - "High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience."
5.	Neoplasms (Cancer) 01/01/2023 - "The present study demonstrates that serum TAMO levels were insignificantly associated with cancer incidence." 01/01/2023 - "Therefore, this systematic review and meta-analysis summarize the effect of TAMO on cancer incidence. " 01/01/2023 - "Glioblastoma exhibits specific infiltration of blood-originated monocytes expressing epidermal growth factor receptor (EGFR) ligands EREG and AREG, coined as tumor-associated monocytes (TAMo). " 01/01/2023 - "Reports on the effect of Trimethylamine-N-oxide (TAMO), a small amine oxide generated by gut microbial metabolism of choline, betaine, and carnitine, on cancer are inconsistent. "

Related Drugs and Biologics

1.	Tamoxifen
2.	trimethyloxamine (trimethylamine N-oxide)
3.	ErbB Receptors (EGF Receptor)
4.	Vitamins
5.	Vitamin D
6.	Serotonin (5 Hydroxytryptamine)
7.	Oxides
8.	Ligands
9.	Hydroxyproline (4 Hydroxyproline)
10.	Volatile Fatty Acids

Related Therapies and Procedures

1.	Stem Cell Transplantation
2.	Drug Therapy (Chemotherapy)
3.	Therapeutics
4.	Transplantation
5.	Physical Therapy Modalities (Physical Therapy Technique)